Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Biologics License Applications for AVT05, their proposed biosimilar to the anti-inflammatory drugs Simponi and Simponi Aria. Review of the applications is expected to by completed in Q4 2025, ...